HLS Therapeutics, Inc. (HLS.TO)
3.75
+0.06
(+1.63%)
CAD |
TSX |
Aug 25, 14:17
HLS Therapeutics Price : 3.75 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 3.70 | 3.77 | 3.64 | 3.69 | 113781.0 |
| Aug 21, 2026 | 3.92 | 3.92 | 3.56 | 3.75 | 126827.0 |
| Aug 20, 2026 | 3.88 | 3.95 | 3.71 | 3.94 | 59900.00 |
| Aug 19, 2026 | 3.93 | 3.94 | 3.71 | 3.87 | 40704.00 |
| Aug 18, 2026 | 3.97 | 3.97 | 3.76 | 3.90 | 12757.00 |
| Aug 17, 2026 | 3.90 | 3.98 | 3.79 | 3.90 | 567607.0 |
| Aug 14, 2026 | 3.90 | 3.99 | 3.88 | 3.90 | 35655.00 |
| Aug 13, 2026 | 3.99 | 4.00 | 3.77 | 3.87 | 288039.0 |
| Aug 12, 2026 | 4.12 | 4.12 | 3.86 | 3.98 | 226460.0 |
| Aug 11, 2026 | 4.00 | 4.06 | 3.81 | 3.83 | 6765.00 |
| Aug 10, 2026 | 4.03 | 4.03 | 3.92 | 3.92 | 13375.00 |
| Aug 07, 2026 | 4.29 | 4.29 | 4.02 | 4.03 | 931.00 |
| Aug 06, 2026 | 4.12 | 4.17 | 3.995 | 4.00 | 4774.00 |
| Aug 05, 2026 | 4.12 | 4.12 | 4.12 | 4.12 | 315.00 |
| Aug 04, 2026 | 4.12 | 4.13 | 4.12 | 4.12 | 504.00 |
| Jul 31, 2026 | 4.20 | 4.21 | 4.08 | 4.20 | 5000.00 |
| Jul 30, 2026 | 4.26 | 4.27 | 4.17 | 4.20 | 12652.00 |
| Jul 29, 2026 | 4.20 | 4.25 | 4.09 | 4.25 | 6249.00 |
| Jul 28, 2026 | 4.20 | 4.215 | 4.14 | 4.21 | 13500.00 |
| Jul 27, 2026 | 4.09 | 4.19 | 4.07 | 4.19 | 4115.00 |
| Jul 24, 2026 | 4.15 | 4.15 | 4.05 | 4.11 | 2450.00 |
| Jul 23, 2026 | 4.15 | 4.24 | 4.10 | 4.11 | 2264.00 |
| Jul 21, 2026 | 4.20 | 4.23 | 4.18 | 4.20 | 9200.00 |
| Jul 20, 2026 | 4.23 | 4.23 | 4.03 | 4.11 | 8748.00 |
| Jul 17, 2026 | 4.25 | 4.25 | 4.11 | 4.11 | 5100.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bausch Health Cos., Inc. | 9.05 |
| Cipher Pharmaceuticals, Inc. | 14.22 |
| BioSyent, Inc. | 15.70 |
| Revive Therapeutics Ltd. | 0.025 |
| Knight Therapeutics, Inc. | 9.71 |
Price Related Metrics
| PS Ratio | 1.510 |
| Price to Book Value | 1.496 |
| Price to Free Cash Flow | 5.371 |
| Earnings Yield | -10.06% |
| Market Cap | 117.26M |